Mersana Therapeutics

Search
  • About
    • Mission & Vision
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Platforms
    • About ADCs
    • DolaLock Technology
    • Dolaflexin
    • Dolasynthen
    • Immunosynthen
  • Pipeline
    • Overview
    • Upifitamab Rilsodotin
    • XMT-1660
    • XMT-2056
  • Publications
  • Investors & Media
    • Overview
    • Stock
    • Analysts
    • SEC Filings
    • News
    • Events
    • Annual Meeting
    • Governance
    • Quarterly Results
    • Contact Us
  • People
    • Culture
    • Benefits
    • Careers
  • Contact

Email Signatures

Executive Signature

FIRST NAME LAST NAME (Pronouns)
Title

P: XXX-XXX-XXXX
M: XXX-XXX-XXXX
E: example@mersana.com

Alternate contact:
FIRST NAME LAST NAME

Mersana Therapeutics

Corporate Signature

FIRST NAME LAST NAME (Pronouns)
Title

P: XXX-XXX-XXXX
M: XXX-XXX-XXXX
E: example@mersana.com

Mersana Therapeutics


© 2023 Mersana Therapeutics, All Rights Reserved. Privacy Policy | Terms of Use
linkedin icon twitter icon
logo
  • About
    • Mission & Vision
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Platforms
    • About ADCs
    • DolaLock Technology
    • Dolaflexin
    • Dolasynthen
    • Immunosynthen
  • Pipeline
    • Overview
    • Upifitamab Rilsodotin
    • XMT-1660
    • XMT-2056
  • Publications
  • Investors & Media
    • Overview
    • Stock
    • Analysts
    • SEC Filings
    • News
    • Events
    • Annual Meeting
    • Governance
    • Quarterly Results
    • Contact Us
  • People
    • Culture
    • Benefits
    • Careers
  • Contact